BF Biosciences Statistics

Total Valuation

BF Biosciences has a market cap or net worth of PKR 16.29 billion. The enterprise value is 16.71 billion.

Market Cap	16.29B
Enterprise Value	16.71B

Important Dates

The last earnings date was Thursday, May 29, 2025.

Earnings Date	May 29, 2025
Ex-Dividend Date	n/a

Share Statistics

BF Biosciences has 88.33 million shares outstanding. The number of shares has increased by 17.77% in one year.

Current Share Class	88.33M
Shares Outstanding	88.33M
Shares Change (YoY)	+17.77%
Shares Change (QoQ)	+6.00%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	1.59%
Float	25.00M

Valuation Ratios

The trailing PE ratio is 35.18.

PE Ratio	35.18
Forward PE	n/a
PS Ratio	3.29
PB Ratio	3.59
P/TBV Ratio	3.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.63, with an EV/FCF ratio of -44.81.

EV / Earnings	42.65
EV / Sales	3.37
EV / EBITDA	18.63
EV / EBIT	22.05
EV / FCF	-44.81

Financial Position

The company has a current ratio of 2.42, with a Debt / Equity ratio of 0.41.

Current Ratio	2.42
Quick Ratio	1.11
Debt / Equity	0.41
Debt / EBITDA	2.06
Debt / FCF	-4.96
Interest Coverage	77.36

Financial Efficiency

Return on equity (ROE) is 11.48% and return on invested capital (ROIC) is 8.71%.

Return on Equity (ROE)	11.48%
Return on Assets (ROA)	6.74%
Return on Invested Capital (ROIC)	8.71%
Return on Capital Employed (ROCE)	11.56%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.71
Inventory Turnover	2.19

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	159.73
200-Day Moving Average	n/a
Relative Strength Index (RSI)	62.86
Average Volume (20 Days)	2,234,542

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BF Biosciences had revenue of PKR 4.96 billion and earned 391.70 million in profits. Earnings per share was 5.24.

Revenue	4.96B
Gross Profit	2.00B
Operating Income	757.55M
Pretax Income	619.99M
Net Income	391.70M
EBITDA	896.83M
EBIT	757.55M
Earnings Per Share (EPS)	5.24

Full Income Statement

Balance Sheet

The company has 1.44 billion in cash and 1.85 billion in debt, giving a net cash position of -411.99 million or -4.66 per share.

Cash & Cash Equivalents	1.44B
Total Debt	1.85B
Net Cash	-411.99M
Net Cash Per Share	-4.66
Equity (Book Value)	4.54B
Book Value Per Share	51.34
Working Capital	2.30B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -137.11 million and capital expenditures -235.70 million, giving a free cash flow of -372.82 million.

Operating Cash Flow	-137.11M
Capital Expenditures	-235.70M
Free Cash Flow	-372.82M
FCF Per Share	-4.22

Full Cash Flow Statement

Margins

Gross margin is 40.44%, with operating and profit margins of 15.28% and 7.90%.

Gross Margin	40.44%
Operating Margin	15.28%
Pretax Margin	12.51%
Profit Margin	7.90%
EBITDA Margin	18.09%
EBIT Margin	15.28%
FCF Margin	n/a

Dividends & Yields

BF Biosciences does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.77%
Shareholder Yield	n/a
Earnings Yield	2.40%
FCF Yield	-2.29%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BF Biosciences has an Altman Z-Score of 4.31.

Altman Z-Score	4.31
Piotroski F-Score	n/a